Login

Carlos de Sousa, CEO, Immunicum 00:00:00

Share On Facebook Share On Twitter

Immunicum

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Cutting Through Financial Confusion with Clear, Flat-Fee Advising
00:10:00
Shaping Africa's Future: Bridgewater's Call to Action | Nir Bar Dea, CO-CEO , Bridgewater Associates LP.
00:10:00
Global Atomic Corporation: Advancing High-Grade Uranium and Zinc Projects
00:10:00
Energy Fuels CEO Mark Chelmer Discusses Strong Financial Position and Strategic Growth in Uranium Market
00:10:00
Breaking the Stigma: Addressing Mental Health and Addiction in the Workplace | Christopher J. Swift, CEO , The Hartford.
00:10:00
When and Why to Consider a Roth Conversion: Evaluating the Benefits and Drawbacks | Sarah Kang, Certified Financial Planner of UAK Diversified Wealth Advisors
00:10:00
Investing in Tomorrow: How AI is Transforming Venture Capital Decisions|Matt Witheiler,partner,Wellington Management
00:10:00
Reward Minerals CEO Lorry Hughes discusses potential acquisition of Beyondie Sulphate of Potash (SOP) Project in Western Australia and the adaptation of potash processing technology.|MR LORRY HUGHES CHIEF EXECUTIVE OFFICER of Reward Minerals
00:10:00
Oregon needs a leader who will challenge conventional thinking, innovate, and make state government accountable to the taxpayer|Allen Alley,CEO,pixelworks inc
00:10:00
CyanConnode's Robust Finances, Strategic Partnerships, and Promising Pipeline Propel Growth | John Cronin, Executive Chairman of cyanconnode holdings plc
00:10:00
Horizon Copper CEO Erfan Kazemi Highlights Strategic Focus on Key Copper Assets, Including Antamina, Oyu Tolgoi, and Hod Maden
00:10:00
Over $6B assets under management, 31 IPOs, and 80+ acquisitions|Rodolfo Gonzalez,General Partner,Foundation Capital

© 2017 - Neuhu+